Our companies are made up of insanely talented people driven to change the world — and many of them are hiring. If you have drive, expertise, and a taste for adventure, we wholeheartedly encourage your interest.
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
1 - 10 employees
Stage
Series A
founded in
2018
X-37 is a pharmaceutical discovery and development company that utilizes an AI-driven approach to drug development, focusing on difficult-to-target proteins across a broad chemical space. The company aims to address high therapeutic value targets that have historically challenged conventional drug discovery, particularly in areas such as autoimmune diseases, cancer, and anticoagulation. With a world-class management team experienced in leading the development and regulatory approval of therapeutics, X-37 builds partnerships with AI companies to leverage cutting-edge technology for identifying small molecules that can effectively bind to these challenging targets, thereby accelerating drug discovery.